Healthcare & Life Sciences
Upstream Bio
United Statesupstreambio.com
Upstream Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
IPOseries-c-plus
series-c-plus
Stage
2018
Founded
2
Investors
About Upstream Bio
Upstream Bio is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Upstream Bio is developing verekitug, a clinical-stage antagonist targeting the TSLP receptor to treat chronic respiratory diseases driven by inflammation, such as severe asthma, CRSwNP, and COPD.
Explore Upstream Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.